✦ LIBER ✦
Nilotinib treatment-associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia
✍ Scribed by Ayalew Tefferi; Louis Letendre
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 659 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.